Journal for ImmunoTherapy of Cancer (Jun 2022)
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
- Takashi Kojima,
- Hiroaki Ikeda,
- Sachiko Okamoto,
- Junichi Mineno,
- Hiroshi Shiku,
- Shigehisa Kitano,
- Shinichi Kageyama,
- Yoshihiro Miyahara,
- Mikiya Ishihara,
- Daisuke Tomura,
- Ikuei Nukaya,
- Tetsuro Sasada,
- Noboru Yamamoto,
- Takashi Watanabe,
- Hideyuki Mishima,
- Alessandra Nardin,
- Evan Newell,
- Hidefumi Kato,
- Hiroyoshi Hattori,
- Takeru Funakoshi,
- Eiichi Sato,
- Hideto Chono,
- Muhammad Faris Kairi,
- Phuong Diem Hoang Nguyen,
- Yannick Simoni,
- Michael Fehlings
Affiliations
- Takashi Kojima
- Ophthalmology, Nagoya Eye Clinic, Nagoya, Japan
- Hiroaki Ikeda
- Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- Sachiko Okamoto
- 1Takara Bio Inc., Kusatsu, Shiga, Japan
- Junichi Mineno
- 1Takara Bio Inc., Kusatsu, Shiga, Japan
- Hiroshi Shiku
- Aff1 grid.260026.0000000040372555XDepartment of Immuno-Gene TherapyMie University Graduate School of medicine Tsu Japan
- Shigehisa Kitano
- Department of Experimental Therapeutics, National Cancer Center Hospital, Goyang, Republic of Korea
- Shinichi Kageyama
- Aff1 grid.260026.0000000040372555XDepartment of Immuno-Gene TherapyMie University Graduate School of Medicine Mie, Tsu Japan
- Yoshihiro Miyahara
- Aff1 grid.260026.0000000040372555XDepartment of Immuno-Gene TherapyMie University Graduate School of Medicine Mie, Tsu Japan
- Mikiya Ishihara
- Aff1 grid.260026.0000000040372555XDepartment of Immuno-Gene TherapyMie University Graduate School of Medicine Mie, Tsu Japan
- Daisuke Tomura
- Aff3 grid.410820.fCenter for Cell and Gene TherapyTakara Bio Inc. Shiga Japan
- Ikuei Nukaya
- Aff3 grid.410820.fCenter for Cell and Gene TherapyTakara Bio Inc. Shiga Japan
- Tetsuro Sasada
- Division of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, Yokohama, Japan
- Noboru Yamamoto
- Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
- Takashi Watanabe
- Department of General Thoracic Surgery, Nara Prefecture General Medical Center, Nara, Japan
- Hideyuki Mishima
- 2Cancer Center, Aichi Medical University, Yazakokarimata, Japan
- Alessandra Nardin
- Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore
- Evan Newell
- 1Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Hidefumi Kato
- Department of Transfusion Medicine, Aichi Medical University, Nagakute, Japan
- Hiroyoshi Hattori
- Laboratory of Advanced Therapy, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
- Takeru Funakoshi
- Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
- Eiichi Sato
- Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
- Hideto Chono
- Takara Bio Inc, Kusatsu, Japan
- Muhammad Faris Kairi
- ImmunoScape Pte. Ltd, Singapore
- Phuong Diem Hoang Nguyen
- ImmunoScape Pte. Ltd, Singapore
- Yannick Simoni
- ImmunoScape Pte. Ltd, Singapore
- Michael Fehlings
- ImmunoScape Pte. Ltd, Singapore
- DOI
- https://doi.org/10.1136/jitc-2021-003811
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.
